Centre for Competition Policy
High quality independent research into competition policy and regulation
Working paper 16-1 v2 [updated July 2017]
Growth and returns to new products and pack varieties: The case of UK pharmaceuticals
AUTHORS: Bennato, AR, Bokhari F & Mariuzzo F
ABSTRACT: We use quarterly sales data from the UK pharmaceuticals market between 2003 and 2013 and estimate the impact of new introductions, i.e., new products and pack varieties within an anatomical therapy class on business unit growth. Using a dynamic lag adjustment growth model that accounts for endogeneity of new introductions, we find that a new product contributes to 18 per cent growth of the business unit while a new pack variety leads to 7 per cent growth for the business unit in the long run. Further, we find that there is significant variation in growth by size of firm and that the marginal effect of additional products on growth is larger for smaller business units. However, the marginal effect of pack varieties does not differ by firm size.
KEYWORDS: Pharmaceuticals, growth, product differentiation, non-linear pricing
CITATION: Bennato, AR, Bokhari, F & Mariuzzo, F (2016) "Growth and returns to new products and pack varieties: The case of UK pharmaceuticals", CCP Working Paper 16-1 v2
Publication Links
New Publications
CCP Book
Behavioural Economics in Competition and Consumer Policy
Subscription Members
The following organisations are subscribed to the CCP Membership Scheme and their support is gratefully acknowledged
[Membership of this scheme or use of members’ logos does not imply agreement by those organisations with any of the views or ideas published by CCP or any of its staff and students]
